Abstract
During the last few years, a variety of technologies have been developed for rapid discovery of protein kinase inhibitors from both synthetic small-molecule libraries and natural products (1–8). Many of high throughput kinase assays have been developed in 96-, 384-, and 1536-well formats using these technologies (9–11). Development of these technologies allow one to quickly large synthetic compound or natural product libraries in a very short period of time with high sensitivity, accuracy, and reproducibility. Therefore, development of these new technologies has significantly accelerated the process of discovering drug leads for kinases. In this chapter, I will summarize and compare a number of technologies for development of homogeneous, high-throughput kinase assays.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beveridge M., Park Y. W. Hermes, J. Marenghi, A. Brophy, and G. Santos, A. (2000) Detection of p56(lck) kinase activity using scintillation proximity assay in 384-well format and imaging proximity assay in 384-and 1536-well format. J. Biomol. Screen 5, 205–212.
Braunwalder A. F., Yarwood D. R, Sills M. A., and Lipson K. E. (1996 a) Measurement of the protein tyrosine kinase activity of c-src using time-resolved fluorometry of europium chelates. Anal. Biochem. 238, 159–164.
Braunwalder A. F., Yarwood D. R., Hall T., Missbach M., Lipson K. E., and Sills M. A. (1996 b) A solid-phase assay for the determination of protein tyrosine kinase activity of c-src using scintillating microtitration plates. Anal. Biochem. 234, 23–26.
Hemmila I. (1999) LANCEtrade mark: homogeneous assay platform for HTS. J. Biomol. Screen. 4, 303–308.
Parker G. J., Law T. L., Lenoch F. J., and Bolger R. E. (2000) Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J. Biomol. Screen. 5, 77–88.
Wouters F. S. and Bastiaens P. (1999) Fluorescence lifetime imaging of receptor tyrosine kinase activity in cell. Curr. Biol. 9, 1127–1130.
Wu J. J., Yarwood D. R., Chaudhuri B., Muller L., Zurini M., and Sills M. A. (2000) Measurement of Cdk4 kinase activity using an affinity peptide-tagging technology. Comb. Chem. High Throughput Screen 3, 27–36.
Wu J. J., Yarwood D. R., Pham Q., and Sills M. A. (2000) Identification of a high affinity anti-phosphoserine antibody for the development of a homogeneous fluorescence polarization assay of Protein Kinase C. J. Biomol. Screening 5, 23–30.
Kowski T. J. and Wu J. J. (2000) Fluorescence polarization is a useful technology for reagent reduction in assay miniaturization. Comb. Chem. High Throughput Screen 3, 437–444.
Fowler A., Swift D., Hemsley P., et al. (2000) A 1536 well fluorescence polarization assay for the Ser/Thr kinase JNK-1, Abstract, the Society for Biomolecular Screening 6th Annual Conference and Exhibition, pp. 196.
Storch E., Ragan S., Born T., Chipman S., and Wu J. J. (2000) Evaluation of different microtiter plate readers for the development of FP and HTR-FRET assays in 384-and 1536-well plates. Abstract for the Society for Biomolecular Screening 6th Annual Conference and Exhibition, pp. 246.
Brophy G., Blair J., and Pither R. (1995) p34cdc2 kinase activity determination using the scintillation proximity assay (SPA). Abstract for the 9th International Conference on Second Messengers and Phosphoproteins. Nashville, TN. pp. 274.
Gobel J., Saussy D. L., and Goetz A. S. (1999) Development of scintillationproximity assays for alpha adrenoceptors. J. Pharmacol. Toxicol. Methods 42, 237–244.
Liu J., Feldman P. A., Lippy J. S., Bobkova E., Kurilla M. G., and Chung T. D. (2001) A scintillation proximity assay for RNA detection. Anal. Biochem. 289, 239–245.
Sherr C. J. (1996) Cancer cell cycles. Science 274, 1672–1677.
Matsushime H., Quelle D. E., Shurtleff S. A., Shibuya M., Sherr C. J., and Kato J. Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066–2076.
Kitagawa M., Higashi H., Jung H. K., Suzuki-Takahashi I., Ikeda M., Tamai K., et al. (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060–7069.
Schmidt T. G. and Skerra, A. (1993) The random peptide library-assisted engineering of a C-terminal affinity peptide, useful for the detection and purification of a functional Ig Fv fragment. Protein Eng. 6, 109–122.
Stenroos K., Hurskainen P., Eriksson S., Hemmila I., Blomberg K., and Lindqvist C. (1998) Homogeneous time-resolved IL-2-IL-2R alpha assay using fluorescence resonance energy transfer. Cytokine 10, 495–499.
Lynch A. B., Loiacono K. A., Tiong C. L., Adams S. E., and MacNeil I. A. (1997) A fluorescence polarization based Src-SH2 binding assay. Anal. Biochem. 247, 77–82.
Wu P., Brasseur M., and Schindler U. (1997) A high-throughput STAT binding assay using fluorescence polarization. Anal. Biochem. 249, 29–36.
Meijer L., Borgne A., Mulner O., Chong J. P., Blow J., Inagaki N., et al. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527–536.
Phelps D. E. and Xiong Y. (1997) Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol. 283, 194–205.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Wu, J.J. (2002). Comparison of SPA, FRET, and FP for Kinase Assays. In: Janzen, W.P. (eds) High Throughput Screening. Methods in Molecular Biology™, vol 190. Humana Press. https://doi.org/10.1385/1-59259-180-9:065
Download citation
DOI: https://doi.org/10.1385/1-59259-180-9:065
Publisher Name: Humana Press
Print ISBN: 978-0-89603-889-9
Online ISBN: 978-1-59259-180-0
eBook Packages: Springer Protocols